Orbia Advance Corporation SAB de CV MXCHY

MaterialsChemicalsMexico

Last close 2.29 USD on Nov 1, 2026, +38.4% year to date

Quant rating

Quant rating B Rank 44 of 220 in Materials

Growth B 59 of 220
Valuation A 27 of 220
Quality B 78 of 220
Revisions B 71 of 220
Momentum C 97 of 220

Wall Street consensus Buy (2.50)Average target 1.57 USD −31.4%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 2.3B
Enterprise value: 7.7B
52-week range: 1.58 – 2.78
3-year range: 1.18 – 5.22
Dividend yield: –
Beta (5 years): 0.52
Shares outstanding: 1,968M
Next earnings: Mar 5, 2027

About the company

Orbia Advance Corporation SAB de CV, formerly Mexichem SAB de CV, is a Mexico-based company engaged in the industrial sector. The Company’s activities are divided into five business groups: Precision Agriculture, Building & Infrastructure, Fluor, Data Communication and Polymer Solutions. The Precision Agriculture business includes Netafim brand, which develops irrigation systems and related services, as well as offers technology for farming digitalization. The Building & Infrastructure business offers pipes for multiple building applications through Wavin brand. The Fluor business operates Koura brand, which manufactures fluorine-based materials used in such industries as healthcare, construction and transportation. The Data Communication business is responsible for production and installation of communication and power cables through Dura-Line brand. The Polymer Solutions business includes vestolit and alphagary brand names, which provides plastic resins and other compounds.

Growth and profitability

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	7,619	7,506	8,204	9,648	8,783	–
Revenue growth	1.5%	−8.5%	−15.0%	9.8%	36.8%	3.5%
EPS (basic, normalized)	−0.23	0.13	0.03	0.28	0.33	–
EPS growth	–	333.3%	−89.3%	−15.2%	–	–
Gross margin	21.3%	23.3%	26.5%	26.6%	29.9%	25.5%
Net margin	−6.0%	1.9%	0.8%	5.9%	7.5%	2.0%
ROE	−20.0%	5.7%	2.5%	21.0%	25.1%	6.9%

Balance sheet, last quarter
Cash & short-term investments (mil)	980
Current ratio	1.51x
Long-term debt (mil)	4,923
Net debt (mil)	5,326
Total equity (mil)	2,252
Net debt / equity	2.37x
Net debt / EBITDA	5.23x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	7,619	+1.5%	1.0x	1,019	−12.8%	7.5x	−0.23	−276.9%	−10.0x
2026	8,438	+10.8%	0.9x	1,267	+24.3%	6.1x	0.02	+109.9%	100.4x
2027	8,662	+2.6%	0.9x	1,337	+5.5%	5.7x	0.09	+300.9%	25.0x
2028	8,935	+3.1%	0.9x	1,438	+7.6%	5.3x	0.10	+12.1%	22.3x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	8,438	+0.8%	+1.9%	+2.5%	0.02	−6.4%	−51.3%	−26.9%
2027	8,662	+2.0%	+3.6%	+2.5%	0.09	+15.4%	+2.7%	+25.4%
2028	8,935	+0.5%	+0.8%	−0.4%	0.10	−2.0%	−11.7%	−5.7%

Earnings surprises

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales reported (mil)	1,863	1,976	1,887	1,780	1,811	1,967	1,966	1,875	1,963	2,352
Sales mean (mil)	1,974	1,975	2,005	1,822	1,721	1,975	1,899	1,883	1,840	2,353
Surprise	−5.6%	0.0%	−5.9%	−2.3%	+5.3%	−0.4%	+3.6%	−0.4%	+6.7%	0.0%
EPS reported	−0.04	0.10	0.05	−0.01	−0.03	−0.07	−0.06	−0.07	−0.02	0.01
EPS mean	0.01	0.03	0.02	0.00	−0.01	0.02	0.01	0.00	−0.01	0.04
Surprise	−816.8%	+225.2%	+121.0%	−340.4%	−362.2%	−389.3%	−628.2%	−3,584.2%	−166.3%	−74.6%

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
MXCHY Orbia Advance Corporation SAB de CV	2.3B	5.23x	−6.0%	1.02x	100.4x	25.0x	6.1x	5.7x
TKCBY Tokai Carbon Co Ltd	2.6B	2.66x	6.2%	1.21x	68.4x	54.8x	8.0x	6.8x
KPLUY K+S AG	2.6B	–	–	–	5.7x	6.7x	–	–
KWR Quaker Chemical Corp	2.6B	2.41x	−0.1%	1.89x	19.2x	16.0x	10.5x	9.5x
NGVT Ingevity Corporation	2.6B	2.77x	−12.9%	54.64x	13.9x	12.3x	9.3x	8.8x
IOSP Innospec Inc	2.5B	−1.20x	6.6%	1.83x	20.2x	16.2x	11.3x	9.4x
Mean		2.38x	−1.2%	12.12x	38.0x	21.8x	9.0x	8.1x
Median		2.66x	−0.1%	1.83x	19.7x	16.1x	9.3x	8.8x

Technical analysis

1M+7.5%
3M−16.4%
1Y+32.4%
3Y−23.8%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Orbia Advance Corporation SAB de CV, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	7,619	7,506	8,204	9,648	8,783	6,420
Cost of revenue	5,993	5,758	6,032	7,079	6,156	4,651
Gross profit	1,626	1,748	2,172	2,569	2,627	1,769
Selling, general & administrative expenses	1,051	1,063	1,135	1,079	1,001	811
Research & development	–	–	–	–	–	–
Depreciation/amortization	180	182	168	164	172	204
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	127	55.0	31.0	143	19.9	31.2
Other operating expenses	−35.0	12.0	−11.0	−9.0	−14.1	1.7
Operating income	303	436	849	1,192	1,449	720
Net interest income (expense)	−367	−329	−353	−146	−291	−240
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	−4.0	−11.0	−11.0	−11.0	−4.1	−1.4
Net income before taxes	−68.0	96.0	485	1,035	1,154	479
Provision for taxes	291	−127	329	369	381	151
Minority interest	−98.0	−78.0	−91.0	−98.0	−115	−124
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	−457	145	65.0	568	658	204
Extraordinary items	–	–	0	−1.0	−0.4	−9.7
Net income	−457	145	65.0	567	657	195
EBIT, normalized	430	491	880	1,335	1,469	752
EBITDA, normalized	1,075	1,151	1,501	1,883	2,033	1,350
Basic EPS, normalized	−0.23	0.13	0.03	0.28	0.33	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Orbia Advance Corporation SAB de CV, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	1,040	1,009	1,456	1,546	782	875
Receivables	1,567	1,448	1,463	1,661	1,596	1,330
Total inventory	1,080	1,098	1,200	1,320	1,292	861
Prepaid expenses	84.0	54.0	50.0	54.0	50.3	60.4
Other current assets	1.0	1.0	1.0	3.0	5.0	29.2
Total current assets	3,772	3,610	4,170	4,584	3,724	3,156
Property, plant & equipment	3,786	3,702	3,839	3,528	3,397	3,510
Goodwill	1,384	1,431	1,447	1,478	1,514	1,491
Intangibles	1,513	1,597	1,702	1,627	1,617	1,734
Long-term investments	66.0	76.0	75.0	58.0	40.3	38.6
Note receivable	–	–	–	–	–	–
Other long-term assets	550	641	319	349	295	282
Total assets	11,071	11,057	11,552	11,624	10,587	10,211
Liabilities
Accounts payable	393	395	381	467	459	538
Payable/accrued	846	821	847	812	1,046	788
Accrued expenses	193	165	194	234	226	160
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	404	659	572	844	326	578
Other current liabilities	651	588	543	688	586	524
Total current liabilities	2,487	2,628	2,537	3,045	2,643	2,588
Long-term debt	4,912	4,424	4,803	4,221	3,561	3,393
Minority interest	831	855	971	1,030	984	961
Other liabilities	706	717	627	660	663	777
Total liabilities	8,936	8,624	8,938	8,956	7,850	7,718
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	256	256	256	256	256	256
Additional paid-in capital	1,475	1,475	1,499	1,475	1,475	1,475
Retained earnings (accumulated deficit)	1,212	1,617	1,843	1,971	1,817	1,508
Treasury stock	–	–	–	–	–	–
Other equity	−808	−915	−984	−1,034	−811	−746
Total equity	2,135	2,433	2,614	2,668	2,737	2,493
Total liabilities & shareholders' equity	11,071	11,057	11,552	11,624	10,587	10,211

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Orbia Advance Corporation SAB de CV, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	−359	223	156	665	772	319
Depreciation, depletion & amortization	649	659	610	581	598	598
Deferred taxes	–	–	–	–	–	–
Non-cash items	789	46.0	690	671	716	421
Changes in working capital	−239	−147	−59.0	−630	−851	−244
Cash from operations	840	781	1,397	1,287	1,235	1,093
Investing activities
Capital expenditures	−385	−405	−589	−470	−286	−204
Other investing cash flows	64.0	−42.0	−107	−292	−57.7	−14.1
Cash from investing	−321	−447	−696	−762	−344	−219
Financing activities
Financing cash flow items	−440	−425	−522	−399	−405	−374
Cash dividends paid	0	−160	−240	−299	−200	−230
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−82.0	−155	−15.0	901	−357	41.5
Cash from financing	−522	−740	−777	203	−962	−562
Foreign exchange effects	34.0	−41.0	−14.0	36.0	−22.1	−24.1
Net change in cash	31.0	−447	−90.0	764	−93.6	289
Free cash flow	455	376	808	817	949	889

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.